Cargando…
Fractional exhaled Nitric Oxide (FeNO) level as a predictor of COVID-19 disease severity
OBJECTIVE: To assess the feasibility of Fractional exhaled Nitric Oxide (FeNO) as a simple, non-invasive, cost-effective and portable biomarker and decision support tool for risk stratification of COVID-19 patients. METHODS: We conducted a single-center prospective cohort study of COVID-19 patients...
Autores principales: | Lior, Yotam, Yatzkan, Noga, Brami, Ido, Yogev, Yuval, Riff, Reut, Hekselman, Idan, Fremder, Moran, Freixo-Lima, Gabriella, Be'er, Moria, Amirav, Israel, Lavie, Moran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116042/ https://www.ncbi.nlm.nih.gov/pubmed/35597408 http://dx.doi.org/10.1016/j.niox.2022.05.002 |
Ejemplares similares
-
Unforeseen changes in seasonality of pediatric respiratory illnesses during the first COVID‐19 pandemic year
por: Be'er, Moria, et al.
Publicado: (2022) -
Lockdown Fatigue in Pediatric Respiratory Patients: Lessons from the First COVID-19 Year
por: Cahal, Michal, et al.
Publicado: (2022) -
Asthma risk after a pediatric intensive care unit admission for respiratory syncytial virus bronchiolitis
por: Be'er, Moria, et al.
Publicado: (2022) -
Rethink Respiratory Rate for Diagnosing Childhood Pneumonia
por: Amirav, Israel, et al.
Publicado: (2019) -
Reply to Shoemark et al. and to Shapiro et al.
por: Amirav, Israel, et al.
Publicado: (2020)